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Abstract
Introduction: Fibronectin fragments (FN-fs) are increased in the cartilage of patients with osteoarthritis (OA) and
have a potent chondrolytic effect. However, little is known about the cellular receptors and signaling mechanisms
that are mediated by FN-fs. We investigated whether the 29-kDa amino-terminal fibronectin fragment (29-kDa FN-f)
regulates cartilage catabolism via the Toll-like receptor (TLR)-2 signaling pathway in human chondrocytes.
Methods: Small interfering RNA was used to knock down TLR-2 and myeloid differentiation factor 88 (MyD88). TLR-2
was overexpressed in chondrocytes transfected with a TLR-2 expression plasmid. The expression levels of matrix
metalloproteinase (MMP)-1, MMP-3, and MMP-13 were analyzed using quantitative real-time reverse transcription
polymerase chain reactions, immunoblotting, or enzyme-linked immunosorbent assay. The effect of TLR-2 on 29-kDa
FN-f-mediated signaling pathways was investigated by immunoblotting.
Results: TLR-2, TLR-3, TLR-4, and TLR-5 mRNA were significantly overexpressed in OA cartilage compared with normal
cartilage, whereas no significant difference of TLR-1 mRNA expression was found. 29-kDa FN-f significantly increased
TLR-2 expression in human chondrocytes in a dose- and time-dependent manner. Knockdown of TLR-2 or MyD88, the
latter a downstream adaptor of TLR-2, significantly inhibited 29-kDa FN-f-induced MMP production at the mRNA and
protein levels. Conversely, TLR-2 overexpression led to enhanced MMP production by 29-kDa FN-f. In addition, TLR-2
knockdown apparently inhibited 29-kDa FN-f-mediated activation of phosphorylated nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor, alpha, and p38, but not of c-Jun N-terminal kinase or extracellular
signal-regulated kinase. Exposure to synovial fluid (SF) from affected joints of patients with OA elevated MMP-1, MMP-3,
and MMP-13 expression markedly in primary chondrocytes without reducing cell viability. However, TLR-2 knockdown
in chondrocytes significantly suppressed SF-induced MMP induction.
Conclusions: Our data demonstrate that the MyD88-dependent TLR-2 signaling pathway may be responsible for
29-kDa FN-f-mediated cartilage catabolic responses. Our results will enhance understanding of cartilage catabolic
mechanisms driven by cartilage degradation products, including FN-f. The modulation of TLR-2 signaling activated by
damage-associated molecular patterns, including 29-kDa FN-f, is a potential therapeutic strategy for the prevention of
cartilage degradation in OA.
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Introduction
Articular cartilage contains abundant extracellular
matrix (ECM), the degradation of which is a central
event leading to joint destruction in many arthritic con-
ditions, including rheumatoid arthritis (RA), osteoarth-
ritis (OA), and septic arthritis [1]. Chondrocytes respond
to a variety of stimuli, including proinflammatory cyto-
kines and mechanical loading, by expressing degradative
enzymes and catabolic mediators [1, 2]. Fibronectin (FN)
is an ECM glycoprotein found in body fluids and many
cell types, and an increase in its expression is associated
with tissue remodeling and repair [3, 4]. In normal car-
tilage, FN is localized mainly in the matrix of the surface
zone. However, in OA, there is an up to tenfold FN ac-
cumulation in cartilage, equivalent to approximately
15 μg/ml wet weight [5]. This results from an increase
in both FN synthesis and accumulation and in FN bind-
ing in the lesion area [6, 7].
In addition, elevated levels of fibronectin fragments
(FN-fs) are found in the OA joint milieu [8]. It has been
estimated that up to 50 % of the FN in arthritic synovial
fluid (SF) is fragmented into molecular sizes of 29–
200 kDa [9]. In OA SF, FN-fs can attain levels greater
than 1 μM due to a combination of increased FN produc-
tion and proteolytic enzyme activation [7]. In particular,
the most potent fragment, 29-kDa amino-terminal fibro-
nectin fragment (29-kDa FN-f), stimulates proteoglycan
breakdown by enhancing nitric oxide (NO) production
[10] and increases the expression levels of matrix me-
talloproteinase (MMP)-1, MMP-3, and MMP-13 [11].
However, little is known about how the FN-fs mediate
catabolic signaling in chondrocytes.
Toll-like receptors (TLRs) have been implicated in
various cellular responses, including innate immunity, a
host defense system against invading pathogens, as well
as in autoimmune and inflammatory diseases [12]. TLRs
are pattern recognition receptors that recognize
pathogen-associated molecular patterns, including bac-
terial peptidoglycan (PGN) and lipopolysaccharide (LPS),
and damage-associated molecular patterns (DAMPs) re-
leased upon tissue injury [13]. The treatment of chon-
drocytes using Staphylococcus aureus PGN and LPS
significantly increased TLR-2 mRNA expression and the
production of MMPs, NO, and prostaglandin E2 [2]. In
addition, microcrystals, including calcium pyrophos-
phate dihydrate and monosodium urate, deposited in the
synovium and articular cartilage stimulate NO produc-
tion via TLR-2-mediated signaling [14].
In the present study, we found that 29-kDa FN-f-
induced catabolic responses were regulated via the mye-
loid differentiation factor 88 (MyD88)-dependent TLR-2
signaling pathway in human articular chondrocytes. Our
results provide new insight into the regulatory mechan-
ism for FN-f-triggered catabolic responses via TLR-2 and
suggest that targeting TLR-2 may have positive thera-
peutic effects in FN-f-aggravated OA cartilage damage.
Methods
Materials and antibodies
Human plasma FN and 120-kDa FN-f were purchased
from EMD Millipore (Temecula, CA, USA). The N-
terminal 45-kDa FN-f and 29-kDa FN-f were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Endotoxin
contained in all reagents, including FN, FN-fs, and SF, was
quantified using a Pierce LAL Chromogenic Endotoxin
Quantitation Kit (Thermo Scientific, Rockford, IL,
USA), and we confirmed that the reagents were
endotoxin-free. Antibodies to MMP-1, MMP-3, and β-
actin were obtained from R&D Systems (Minneapolis,
MN, USA). Antibodies to phosphorylated c-Jun N-
terminal kinase (p-JNK), phosphorylated p38 (p-p38),
phosphorylated nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, alpha (p-IκBα), and
phosphorylated extracellular signal-regulated kinase (p-ERK)
were purchased from Cell Signaling Technology (Danvers,
MA, USA). Horseradish peroxidase-conjugated secondary
antibodies were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA).
Patients
Cartilage samples were obtained at the time of total knee
replacement surgery from OA patients [n = 20, mean ±
standard deviation (SD) age 71.5 ± 7.3 years] who were
diagnosed according to the American College of
Rheumatology criteria [15, 16]. Normal cartilage samples
were obtained from patients with femoral neck fractures
with no known history of OA or RA (n = 15, mean ± SD
age 69.8 ± 11.2 years). The collection and use of human
tissue samples were reviewed and approved by the insti-
tutional review board of Hallym University Sacred Heart
Hospital (Anyang, Korea; approval number 2013-I022).
All patients provided written informed consent.
Cell culture
We isolated primary human chondrocytes from articular
cartilage that was dissected and subjected to sequential
digestion using protease from Streptomyces griseus
(Sigma-Aldrich), collagenase from Clostridium histolyti-
cum (Sigma-Aldrich), and hyaluronidase from bovine
testes (Sigma-Aldrich) in Dulbecco’s modified Eagle’s
medium (DMEM; Life Technologies, Frederick, MD,
USA). Chondrocytes were maintained in DMEM con-
taining 10 % fetal bovine serum and 1 % penicillin-
streptomycin. The cells were incubated at 37 °C in a
humidified atmosphere of 5 % CO2, and the medium
was changed every 2–3 days. First-passage cultured hu-
man chondrocytes were used for all experiments within
3–6 days after seeding.
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Transfection of small interfering RNAs and plasmids
TLR-2, MyD88, and control small interfering RNA
(siRNA) were purchased from Bioneer (Daejeon, Korea).
A mammalian expression plasmid containing human
TLR-2 and empty vector were obtained from Addgene
(Cambridge, MA, USA). The effects of siRNA and the
expression plasmid were monitored using quantitative
real-time reverse transcription polymerase chain reac-
tions (qRT-PCRs). Human chondrocytes were trans-
fected with 50 nM siRNA or 0.5 μg of expression
plasmid using the calcium phosphate precipitation
method [17]. Forty-eight hours after transfection, the
cells were stimulated with 29-kDa FN-f for the indicated
time periods and used for the following experiments.
Transfection of small interfering Toll-like receptor 2
(siTLR-2) did not lead to higher cell death than control
siRNA transfection as assessed by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide assay.
qRT-PCR analysis
Total RNA was extracted using a standard protocol
with TRIzol reagent (Invitrogen/Thermo Fisher Scien-
tific, Carlsbad, CA, USA). In some studies, cartilage
tissue from the knees of normal and OA donors was
crushed to a fine powder in liquid nitrogen, and total
RNA was prepared as described above. The first-
strand cDNA was synthesized from 2 μg of total
RNA, using Moloney murine leukemia virus reverse
transcriptase (Promega, Madison, WI, USA). The
PCRs were performed using the LightCycler FastStart
DNA Master SYBR Green I kit (Roche Diagnostics,
Mannheim, Germany) and a LightCycler 2.0 Instru-
ment (Roche Diagnostics, Indianapolis, IN, USA).
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was used as a reference gene. Primer sequences were
as follows: TLR-1 forward 5′-AGT TGT CAG CGA
TGT GTT CG-3′, reverse 5′-AAA ATC CAA ATG
CAG GAA CG-3′; TLR-2 forward 5′-CCT CCA ATC
AGG CTT CTC TG-3′, reverse 5′-TGG AGG TTC
ACA CAC CTC TG-3′; TLR-3 forward 5′-AGC CTT
CAA CGA CTG ATG CT-3′, reverse 5′-TTT CCA
GAG CCG TGC TAA GT-3′; TLR-4 forward 5′-TGA
GCA GTC GTG CTG GTA TC-3′, reverse 5′-CAG
GGC TTT TCT GAG TCG TC-3′; TLR-5 forward
5′-GGA ACC AGC TCC TAG CTC CT-3′, reverse
5′-AAG AGG GAA ACC CCA GAG AA-3′; MyD88
forward 5′-GCA CAT GGG CAC ATA CAG AC-3′,
reverse 5′-GAC ATG GTT AGG CTC CCT CA-3′;
MMP-1 forward 5′-AGT GAC TGG GAA ACC AGA
TGC TGA-3′, reverse 5′-GCT CTT GGC AAA TCT
GGC GTG TAA-3′; MMP-3 forward 5′-GCG TGG
ATG CCG CAT ATG AAG TTA-3′, reverse 5′-AAA
CCT AGG GTG TGG ATG CCT CTT-3′; MMP-13
forward 5′-AAG GAC CCT GGA GCA CTC ATG
TTT-3′, reverse 5′-TGG CAT CAA GGG ATA AGG
AAG GGT-3′; GAPDH forward 5′-TGA TGA CAT
CAA GAA GGT GGT GAA G-3′, reverse 5′-TCC
TTG GAG GCC ATG TGG GCC AT-3′.
Western blot analysis
Following 29-kDa FN-f stimulation, culture supernatants
were collected, and the cells were washed with cold
phosphate-buffered saline and lysed in lysis buffer [50 mM
sodium acetate, pH 5.8, 10 % sodium dodecyl sulfate
(SDS), 1 mM ethylenediaminetetraacetic acid, 1 mM phe-
nylmethylsulfonyl fluoride, and 1 μg/ml aprotinin] at 4 °C.
Proteins were subjected to 10 % SDS-polyacrylamide gel
electrophoresis and transferred to polyvinylidene difluoride
membranes (EMD Millipore). After blocking with 5 %
nonfat milk in Tris-buffered saline plus 0.1 % Tween 20,
the membranes were incubated with primary antibodies to
MMP-1, MMP-3, p-JNK, p-p38, p-IκBα, p-ERK, or β-actin.
The membrane was developed using an enhanced chemi-
luminescence kit (Santa Cruz Biotechnology).
MMP-13 enzyme-linked immunosorbent assay
The human chondrocyte culture supernatants were
harvested following 29-kDa FN-f stimulation for 24 h,
and the MMP-13 protein level was determined by
enzyme-linked immunosorbent assay (ELISA) using a
pro-MMP-13 immunoassay kit according to the man-
ufacturer’s instructions (R&D Systems). Plates were
read at 450 nm using a Thermo Scientific Multiskan
GO Microplate Spectrophotometer (Thermo Fisher
Scientific, Vantaa, Finland).
Preparation of synovial fluid samples
SF was obtained from patients with OA [n = 4, age
(mean ± SD) 73.0 ± 14.7 years] and centrifuged at
14,000 rpm for 10 minutes to remove cells and joint
debris. The SF supernatants were stored at −80 °C
until used for assays. Chondrocytes transfected with
TLR-2 or control siRNA were exposed to SF diluted
with serum-free DMEM for 24 h, washed twice with
serum-free DMEM, and incubated in serum-free
DMEM for 24 h. The levels of MMP-1 and MMP-3
released from the chondrocytes were determined
using Western blot analysis and that for MMP-13 was
determined by ELISA.
Statistical analysis
The results are expressed as means ± SD. Statistical ana-
lysis was performed using the Mann–Whitney U test or
two-way analysis of variance. P < 0.05 was taken to indi-
cate statistical significance. All experiments were re-
peated at least in triplicate, and representative data are
presented.
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Results
Differential expression of TLR family members in normal
and OA cartilage and fibronectin fragment-regulated
TLR-2 expression
On the basis of previous reports on the differential expres-
sion of specific TLR family members in human articular
chondrocytes from normal and OA cartilage [2, 18], we
investigated differences in the expression of the TLR-1–
TLR-5 genes in normal and OA cartilage. qRT-PCR ana-
lysis showed that the TLR-1–TLR-5 genes were expressed
in both normal and OA cartilage (Fig. 1a). Although basal
expression levels varied from individual to individual,
TLR-2, TLR-3, TLR-4, and TLR-5 expression levels were
significantly elevated in OA cartilage compared with nor-
mal cartilage. In contrast, the TLR-1 expression levels did
not differ between normal and OA cartilage (Fig. 1a).
Next, we decided to determine whether TLR-2 expression
can be regulated by potential endogenous ligand FN-fs.
TLR-2 expression in human chondrocytes was signifi-
cantly enhanced by 45-kDa and 29-kDa FN-fs in a time-
and dose-dependent manner (Fig. 1b). In particular,
29-kDa FN-f induced the highest level of TLR-2 expres-
sion, whereas intact FN did not change TLR-2 expression,
and 120-kDa FN-f (300 nM) significantly increased TLR-2
expression only at 24 h compared with untreated human
chondrocytes (Fig. 1b). 29-kDa FN-f slightly but signifi-
cantly increased TLR-1, TLR-3, and TLR-4 expression
levels after 6 h of stimulation (Additional file 1). These
results suggest that the increased TLR-2 expression in
OA cartilage may be related to FN-f products generated
by cartilage destruction.
29-kDa FN-f stimulates TLR-2-dependent procatabolic
responses in human articular chondrocytes
Although it has been reported that FN-fs play important
roles in the catabolic responses of human chondrocytes,
Fig. 1 Differential expression of Toll-like receptor (TLR) family members in normal and osteoarthritic (OA) cartilage and fibronectin
fragment (FN-f)-regulated TLR-2 expression in human chondrocytes. a Expression of the TLR-1–TLR-5 genes in normal and OA cartilage
was determined using SYBR Green-based real-time polymerase chain reaction. The expression level of TLR family members was normalized
to that of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Cycle threshold changes (ΔCt) were calculated by subtracting Ct values
of GAPDH from Ct values of TLR family members. The mean value of gene expression level in normal cartilage was designated as 1 in
each experiment. Also, the expression levels of TLR family members were described as raw Ct values. Data represent the mean ± SD for
duplicate experiments from ten separate donors. Lines within the boxes represent the median, boxes represent the 25th and 75th percentiles, and
lines outside the boxes correspond to the minimum and maximum values. b TLR-2 mRNA expression levels in OA chondrocytes were measured at 6,
12, and 24 h after treatment with intact FN or various FN-fs. The expression level of TLR-2 was described as raw Ct values as well as relative values,
normalized to that of GAPDH. Data represent the mean ± SD for triplicate experiments from three different donors (n = 3). *P < 0.05, **P < 0.01, and
***P < 0.001 vs. control
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the precise mechanism remains unclear. To investigate
the involvement of TLR-2 in 29-kDa FN-f-mediated
MMP production in human chondrocytes, we knocked
down TLR-2 in these cells using siTLR-2. RT-PCR ana-
lysis revealed significant inhibition of TLR-2 expression
(80 %) after the introduction of siTLR-2 (Fig. 2a). In nor-
mal and OA chondrocytes, 29-kDa FN-f-induced mRNA
expression levels of MMP-1, MMP-3, and MMP-13 were
reduced significantly by siTLR-2 (Fig. 2b). Consistent
with mRNA expression pattern, 29-kDa FN-f-mediated
protein production of these MMPs was also significantly
suppressed by siTLR-2 treatment (Fig. 2c and d). In con-
trast, TLR-2 overexpression by transfection with TLR-2
expression vector (Fig. 3a) resulted in significant upregu-
lation of the 29-kDa FN-f-induced mRNA expression of
these MMPs compared with mock vector-transfected
chondrocytes (Fig. 3b). Likewise, 29-kDa FN-f-induced
MMP protein synthesis was enhanced significantly in
TLR-2-overexpressing cells (Fig. 3c and d). These data
indicate that TLR-2 is involved in 29-kDa FN-f-
stimulated MMP production in human chondrocytes.
Regulatory effects of TLR-2 on 29-kDa FN-f-mediated
catabolic signaling pathways in human articular
chondrocytes
To determine whether TLR-2 regulates 29-kDa FN-f-
mediated signaling pathways, human chondrocytes were
transfected with siTLR-2 or control siRNA. Forty-eight
hours after transfection, cells were starved using serum-
free media for 24 h and then treated with 29-kDa FN-f
for the indicated time periods, and the regulatory effects
of TLR-2 on 29-kDa FN-f-induced signaling pathways
were determined using Western blot analysis. Interest-
ingly, the phosphorylation of IκBα and p38 was appar-
ently inhibited in siTLR-2-transfected cells compared
with control siRNA-transfected cells (Fig. 4a and b). In
contrast, the phosphorylation of JNK and ERK1/2 was
not affected by siTLR-2 in human chondrocytes (Fig. 4a
and b). These data indicate that the 29-kDa FN-f-
driven activation of the nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) and p38
signaling pathways may be associated with TLR-2 in
human chondrocytes.
29-kDa FN-f upregulates MMP secretion via a MyD88-
dependent TLR-2 signaling pathway in human articular
chondrocytes
To further elucidate the molecular mechanism under-
lying the regulatory effect of TLR-2 on 29-kDa FN-f-
stimulated MMP production, we transfected human
articular chondrocytes with siMyD88 or control siRNA
and stimulated them with 29-kDa FN-f. MyD88 siRNA
transfection decreased MyD88 mRNA expression in
chondrocytes (Fig. 5a). The MMP-1, MMP-3, and
MMP-13 mRNA expression levels were significantly re-
duced in siMyD88-transfected cells compared with the
control siRNA-transfected cells (Fig. 5b). In addition,
MyD88 knockdown significantly reduced 29-kDa FN-f-
induced MMP-1 and MMP-3 protein secretion as well
as MMP-13 secretion, as demonstrated using Western
blot analysis and ELISA, respectively (Fig. 5c and d).
These results suggest that 29-kDa FN-f-induced MMP
production is regulated by a MyD88-dependent TLR-2
signaling pathway in human chondrocytes.
TLR-2 knockdown suppresses OA synovial fluid-induced
MMPs production
To determine whether the SF of patients with OA in-
duces MMP production through TLR-2, we transfected
human chondrocytes using siTLR-2, siMyD88, or control
siRNA, followed by treatment with SF serially diluted
using serum-free media. The diluted SF had little effect on
chondrocyte viability (data not shown). Western blot ana-
lysis (Fig. 6a and c) and ELISA (Fig. 6b and d) showed that
SF at up to 1:10 dilution upregulated MMP-1, MMP-3,
and MMP-13 synthesis in the control siRNA-transfected
cells. However, TLR-2 and MyD88 knockdown signifi-
cantly suppressed SF-induced MMP synthesis (Fig. 6a–d).
We could not detect MMP-1, MMP-3, or MMP-13 in SF-
exposed media in the absence of chondrocytes (see
Additional file 2A and B). We examined whether FN-fs in
SF mediate MMP expression in chondrocytes by neutral-
izing FN-fs with an antibody against FN. Anti-FN anti-
body significantly reduced SF-induced MMP release from
chondrocytes (Additional file 2C and D), meaning that FN
or FN-fs in SF attach to receptors, including TLR-2, on
chondrocytes and subsequently induce MMPs expression.
These data showed that OA SF, which contains various
DAMP species, at least in part upregulates MMP produc-
tion via a TLR-2-mediated signaling pathway.
Discussion
In this study, we demonstrated that TLR-2, TLR-3, TLR-4,
and TLR-5, which play an important role in innate im-
munity, are more abundantly expressed in OA cartilage
than in normal cartilage. Among the different FN-fs inves-
tigated, 29-kDa FN-f upregulated TLR-2 expression most
potently. 29-kDa FN-f upregulated MMP-1, MMP-3, and
MMP-13 expression in chondrocytes via a MyD88-
dependent TLR-2 signaling pathway.
FN, an important component of articular cartilage
matrix, is composed of a series of homologous domains
that form an extended flexible molecule that is extremely
sensitive to proteolytic digestion [19]. FN-fs, generated by
proteolytic cleavage of FN, are found at elevated levels in
OA cartilage and SF [20–22], consequently inducing cata-
bolic mediators and the degradation of cartilage collagen
[11]. The 29-kDa, 50-kDa, and 140-kDa FN-fs, which have
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Fig. 2 Small interfering Toll-like receptor 2 (siTLR-2) knockdown of endogenous TLR-2 expression suppresses 29-kDa amino-terminal fibronectin
fragment (29-kDa FN-f)-induced matrix metalloproteinase (MMP) production in normal and osteoarthritis (OA) chondrocytes. Chondrocytes were
transfected with siTLR-2 or control small interfering RNA (siRNA). Cells were stimulated 48 h after transfection using different concentrations of
29-kDa FN-f for 6 or 24 h. a Real-time reverse transcription polymerase chain reaction (RT-PCR) analysis demonstrated specific inhibition of TLR-2
expression by siRNA against TLR-2. b In normal and OA chondrocytes, MMP-1, MMP-3, and MMP-13 mRNA expression was analyzed using SYBR
Green RT-PCR. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control. The mRNA expression level in untreated
control siRNA transfected chondrocytes was set as 1. Data represent the mean ± SD for triplicate experiments from three different donors.
*P < 0.05, **P < 0.01, and ***P < 0.001 vs. control. c Secretion of MMP-1 and MMP-3 in supernatants of 29-kDa FN-f-stimulated chondrocytes was
assessed using Western blot analysis. Data are representative of four independent experiments from different donors with similar results. d MMP-13
production in culture supernatants was determined by enzyme-linked immunosorbent assay. Each value represents the mean ± SD of triplicate
experiments from three different donors. *P < 0.05 and **P < 0.01 vs. control siRNA-transfected chondrocytes
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Fig. 3 Increased Toll-like receptor (TLR)-2 expression promotes 29-kDa amino-terminal fibronectin fragment (29-kDa FN-f)-induced matrix
metalloproteinase (MMP) production in normal and osteoarthritis (OA) chondrocytes. Human chondrocytes were transfected using a TLR-2
expression vector or empty vector as a control. a TLR-2 expression was upregulated in chondrocytes transfected with TLR-2 expression vectors.
b TLR-2 overexpression significantly increased MMP-1, MMP-3, and MMP-13 mRNA expression compared with cells transfected with empty vector.
The mRNA expression level in untreated control small interfering RNA transfected chondrocytes was set as 1. Data represent the mean ± SD for
triplicate experiments from three different donors. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. control. c The 29-kDa FN-f-induced release of MMP-1
and MMP-3 was analyzed using Western blot analysis. TLR-2 overexpression enhanced the synthesis of MMP-1 and MMP-3 in normal and OA
chondrocytes. d MMP-13 production in culture supernatants was determined by enzyme-linked immunosorbent assay. The 29-kDa FN-f-induced
MMP-13 production was significantly higher in cells transfected with the TLR-2 expression vector. The bars represent the mean ± SD of triplicate
samples from three different donors. *P < 0.05 and **P < 0.01 vs. empty vector-transfected chondrocytes
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been studied the most extensively, have a different affinity
for cartilage matrix molecules. 29-kDa FN-f shows affinity
for heparin, 50-kDa FN-f for gelatin and collagen, and
140-kDa FN-f for heparin and the protein core of heparan
sulfate proteoglycan [23]. Although each FN-f may possess
specific proteolytic activities, FN-f-induced cartilage ca-
tabolism results mostly from increased MMP expression
and activity [24, 25]. 29-kDa FN-f was reported to be the
most potent inducer of cartilage catabolism, which was
corroborated by an in vivo study showing that 29-kDa
FN-f injection into rabbit knee joints caused up to 70 %
loss of total cartilage proteoglycan within 7 days [26]. In
addition to MMPs, 29-kDa FN-f was shown to induce
procatabolic cytokines, including interleukin (IL)-1α, IL-1β,
IL-6, and tumor necrosis factor (TNF)-α, as well as NO
production, in human and bovine cartilage [27].
FN is known to bind several receptors of the integrin
family [22, 28], and 120-kDa FN-f, which contains the
cell-binding RGD sequence, may bind to and stimulate
the α5β1 integrin receptor, subsequently increasing cyto-
kine and chemokine expression through p38 or JNK
mitogen-activated protein kinase (MAPK) activation and
the NF-κB-dependent pathway [29, 30]. On one hand, the
use of RGD analogues resembling the integrin binding se-
quence suggested that 29-kDa and 50-kDa FN-fs exert
their effects independently of integrin interactions [31].
On the other hand, it was shown that FN-fs, including 29,
50, and 140 kDa, were cross-linked to the integrin
receptor subunit α5, and the presence of an antisense
oligonucleotide to the α5 subunit of integrin partially re-
versed the ability of the FN-fs to suppress proteoglycan
synthesis in cartilage explants and high-density chondro-
cyte cultures [32]. A subject of our further investigation is
to see whether α5 knockdown has a synergistic effect in
the TLR-2 mediation of FN-f response.
Products of cartilage matrix degradation, including
FN-fs, hyaluronan fragments, and collagen hydroly-
sates, are known to play a role as DAMPs and may
form a vicious cycle for accelerating cartilage matrix
damage [11, 14, 21, 27, 33]. Considerable evidence
from many studies suggests that the cellular level and
expression of different TLRs could be related to the
homeostasis of cartilage matrix. TLRs in articular cartilage
and cultured chondrocytes are known to be increased in
OA [34, 35]. Furthermore, TLR-2 expression is upregulated
by catabolic cytokines, including IL-1β, and TLR-2 ligands,
including 45-kDa and 29-kDa FN-f, which strongly induce
catabolic responses in chondrocytes [2, 35]. In addition,
TLR-2 can recognize endogenous ligands, including mono-
sodium urate crystal [35] and hyaluronan fragments [14].
In the present study, we demonstrated a strong up-
regulation of TLR-2 by 29-kDa FN-f and a relatively
weak but significant increase by 45-kDa FN-f, as well
as upregulation of TLR-2 in OA cartilage compared
with normal cartilage, suggesting a relationship be-
tween catabolic signaling induced by FN-fs and TLR-2.
Fig. 4 Small interfering Toll-like receptor 2 (siTLR-2) knockdown of endogenous TLR-2 expression inhibits 29-kDa amino-terminal fibronectin
fragment (29-kDa FN-f)-mediated catabolic pathways in human chondrocytes. a To investigate the effect of TLR-2 on 29-kDa FN-f-induced signal
pathways, human chondrocytes were transfected using control small interfering RNA (siRNA) or siTLR-2. After transfection, the cells were stimulated
using 29-kDa FN-f for the indicated times, and the levels of phosphorylated nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,
alpha (p-IκBα), phosphorylated c-Jun N-terminal kinase (p-JNK), phosphorylated p38 (p-p38), and phosphorylated extracellular signal-regulated kinase
(p-ERK) were determined using Western blot analysis. Western blot data are representative of three independent experiments from different donors
with similar results. b The relative phosphorylation level of JNK, ERK, p38, and IκBα proteins. Protein density was normalized to the respective
unphosphorylated proteins. The bars represent the mean ± SD of three independent experiments from different donors with similar results.
*P < 0.05 and **P < 0.01 vs. control siRNA-transfected chondrocytes. Ctl, control
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Fig. 5 (See legend on next page.)
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Hyaluronan fragments increased proinflammatory cyto-
kines by activating CD44 and TLR-4 in chondrocytes,
indicating a role for DAMP recognition by TLR in car-
tilage damage progression [33]. In addition, MyD88-
dependent TLR-2/TLR-4 signaling was demonstrated to
be essential for procatabolic responses to low molecular
weight hyaluronan and high-mobility group box chromo-
somal protein 1 [14]. In agreement with previous studies,
we found that 29-kDa FN-f significantly activated procata-
bolic responses in human articular chondrocytes, which
was mediated through TLR-2. In contrast, knocking down
TLR-4 did not have a significant influence on the 29-kDa
FN-f-mediated catabolic response (data not shown). Al-
though the unavailability of suitable antibodies and tech-
nical challenges prevented us from confirming the direct
binding of FN-fs to chondrocyte TLR-2 in the immuno-
precipitation assay, the interaction of fluorescently labeled
29-kDa FN-f with chondrocytes was abolished by using
excess TLR-2 antibody, suggesting a direct interaction
(data not shown).
Downstream signaling pathways of TLRs include
MyD88-dependent and MyD88-independent pathways
[13]. MyD88, a Toll/IL-1 receptor (TIR) adaptor, modu-
lates TLR signaling pathways, with the exception of the
(See figure on previous page.)
Fig. 5 Myeloid differentiation factor 88 (MyD88)-dependent Toll-like receptor (TLR)-2 signaling pathway regulates 29-kDa amino-terminal fibronectin
fragment (29-kDa FN-f)-induced matrix metalloproteinase (MMP) production in normal and osteoarthritis (OA) chondrocytes. To determine the
involvement of the MyD88-dependent TLR-2 signaling pathway in 29-kDa FN-f-triggered catabolic responses, human chondrocytes were transfected
using control small interfering RNA (siRNA) or small interfering MyD88 (siMyD88). After 48 h, the cells were stimulated using 29-kDa FN-f for 6 or 24 h.
a Inhibition of MyD88 expression by siMyD88. b Effect of siMyD88 on mRNA expression of 29-kDa FN-f-induced MMPs was determined using SYBR
Green real-time reverse transcription polymerase chain reaction. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control.
In normal and OA chondrocytes, the expression of MMP-1, MMP-3, and MMP-13 mRNA were reduced significantly by siMyD88 treatment. The mRNA
expression level in untreated control siRNA transfected chondrocytes was set as 1. Data represent the mean ± SD for triplicate experiments from three
different donors. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. control. c MMP-1 and MMP-3 protein levels in culture supernatants were determined using
Western blot analysis. d Enzyme-linked immunosorbent assay showed that 29-kDa FN-f-triggered MMP-13 production was suppressed significantly in
siMyD88-transfected cells compared with siRNA-transfected control cells. Values represent the mean ± SD of triplicate samples from three different
donors. *P < 0.05 and **P < 0.01 vs. control siRNA-transfected chondrocytes
Fig. 6 Synovial fluid-induced matrix metalloproteinase (MMP) expression was suppressed by Toll-like receptor (TLR)-2 and myeloid differentiation
factor 88 (MyD88) knockdown. a TLR-2 in chondrocytes was knocked down by small interfering TLR-2 (siTLR-2) transfection, after which cells were
treated with sequentially diluted synovial fluid. MMP-1 and MMP-3 expression levels in culture media were determined using Western blot
analysis. b The expression levels of MMP-13 in culture media were determined by enzyme-linked immunosorbent assay (ELISA). Data represent
the means ± SD for triplicate experiments from three different donors. c MyD88 in chondrocytes was knocked down by small interfering MyD88
(siMyD88) transfection, after which cells were treated with sequentially diluted synovial fluid. MMP-1 and MMP-3 expression levels in culture
media were determined using Western blot analysis. d The expression levels of MMP-13 in culture media were determined using ELISA. Control
untreated with synovial fluid, control siRNA control small interfering RNA-transfected cells, siTLR-2 small interfering TLR-2 RNA-transfected cells,
siMyD88 small interfering MyD88 RNA-transfected cells. Data represent the mean ± SD for triplicate experiments from three different donors.
*P < 0.05, **P < 0.01, and ***P < 0.001 vs. control siRNA-transfected chondrocytes
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TLR-3 and MyD88-independent TLR-4 signaling path-
ways [36]. Upon stimulation, activated TLR-2 transiently
forms a complex with MyD88 via interaction between
individual TIR domains. In addition, IL-1 receptor-
associated kinase and TNF receptor-associated factor 6
are recruited to the receptor signaling complex, finally
activating the MAPK and transcription regulators, in-
cluding activator protein 1 and NF-κB, the latter mediat-
ing the expression of several proinflammatory cytokines
and other inflammatory molecules [13, 37]. We found
that knocking down TLR-2 significantly suppressed
downstream signaling pathways mediated by FN-fs, in-
cluding NF-κB and p38. In addition, knocking down
MyD88 uniformly inhibited MMP upregulation medi-
ated by FN-fs. Previous studies demonstrated that FN-f
containing the RGD cell-binding domain stimulated
small GTPase Rac1 signaling in addition to MAPK and
NF-κB signaling pathways in human chondrocytes,
which were involved in MMP-13 expression [20, 29].
Whether TLR-2 mediates pathways regulated by other
FN-fs is the subject of further research.
It was reported previously that factors produced by the
synovium may stimulate OA chondrocytes to express
catabolic mediators. For example, OA SF significantly up-
regulated p55 TNF receptor expression in chondrocytes
compared with normal serum [38]. Chondrocyte death
was observed after exposure of chondrocytes to RA SF
but not to OA SF, and active secretion of cytokines, in-
cluding vascular endothelial growth factor, by chondro-
cytes treated with OA SF was observed [39], suggesting a
role for OA SF in the stimulation of a catabolic response
in OA. In addition to the cellular elements of the syno-
vium, it is plausible that OA SF also contains cartilage
degradation products. We demonstrated that OA SF in-
creased MMP expression in OA chondrocytes, which was
mediated partly via TLR-2. Neutralizing antibody against
FN significantly reduced SF-induced MMP release from
chondrocytes, meaning that FN or FN-fs in SF attach to
receptors, including TLR-2, on chondrocytes and subse-
quently induce MMPs. This result is compatible with our
hypothesis that DAMP contained in SF may at least in
part lead to cartilage degradation via TLR-2.
Conclusions
Our results demonstrate that 29-kDa FN-f may induce
catabolic responses, including MMP expression, by acti-
vation of NF-κB and p38 through an MyD88-dependent
TLR-2 signaling pathway in articular chondrocyte cul-
ture (see Additional file 3). DAMP contained in SF may
lead at least in part to cartilage degradation via TLR-2.
Our study therefore provides additional evidence that
the TLR-2-mediated signaling pathway may contribute
to cartilage matrix degradation in OA and thus could
serve as a useful therapeutic target for OA.
Additional files
Additional file 1: TLR-1, TLR-3, TLR-4, and TLR-5 mRNA expression
levels in OA chondrocytes were measured at 6 h after treatment
with intact FN or various FN-fs. The expression level of TLR family
members was described as raw Ct values as well as relative values
normalized to GAPDH. Data represent the mean ± SD for triplicate
experiments from three different donors (n = 3). A significant increase
(*P < 0.05) or a significant decrease (#P < 0.05, ##P < 0.001) vs. control.
(PPTX 69 kb)
Additional file 2: The release of MMP-1, MMP-3, and MMP-13 into
culture medium in SF-treated chondrocytes. Chondrocytes were
incubated with sequentially diluted SF for 24 h, washed twice with
serum-free DMEM, and incubated in serum-free DMEM for 24 h. Also,
control medium was prepared by incubating with diluted SF only
(without chondrocytes), washing with serum-free DMEM, and incubating
in serum-free DMEM for 24 h. Then the medium was collected for
analysis of MMP-1, MMP-3, and MMP-13 release into culture medium. A The
levels of MMP-1 and MMP-3 in culture media were determined using
Western blot analysis. C control, untreated with SF. B The expression levels
of MMP-13 in culture media were determined using ELISA. Data represent
the mean ± SD for triplicate experiments from three different donors. *P <
0.05 vs. control treated with SF in the absence of chondrocytes.
C and D Release of MMP-1, MMP-3, and MMP-13 induced by SF was
reduced by neutralization of SF with neutralizing antibody (FN antibody). SF
was neutralized with diluted neutralizing antibody [fibronectin antibody
(N-20), sc-6953] against FN for 6 h. Chondrocytes were exposed for 24 h to
the neutralized SF, washed twice with serum-free DMEM, and incubated in
serum-free DMEM for additional 24 h. Then the medium was collected for
analysis of MMP-1, MMP-3, and MMP-13 release into the culture medium. SF
1:2 diluted synovial fluid. Dilution factor of neutralization antibody, 1:4, 1:8,
and 1:16. C The levels of MMP-1 and MMP-3 in culture media were determined
using Western blot analysis. D Release of MMP-13 in the culture media was
determined using ELISA. Data represent the mean ± SD for triplicate
experiments from three different donors. #P < 0.05, ##P < 0.01, and ###P <
0.001 vs. untreated control. ***P < 0.001 vs. SF-treated cells. (PPTX 127 kb)
Additional file 3: Schematic signaling pathway through which
29 kDa FN-f mediated MMP expression via TLR-2. (PPTX 40 kb)
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